Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5884685 | Journal of Clinical Anesthesia | 2016 | 10 Pages |
Abstract
Although a longer duration follow-up study in a larger patient population would expand our understanding of potential CV risks, the present analysis suggests that postoperative use of HPβCD-diclofenac does not present an added CV safety risk over placebo.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Tong J. (Professor and Chairman), Neil (Chief Scientific Officer), Stephen E. (Vice President, Clinical Research), Peter G. (Vice President, Adjunct Assistant Professor of Medicine), Lauren H. (Regional Scientific Manager),